- Home
- KOSS vs BCLI Comparison
KOSS vs BCLI Comparison
Compare KOSS & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- BCLI
- Stock Information
- Founded
- KOSS 1953
- BCLI 2000
- Country
- KOSS United States
- BCLI United States
- Employees
- KOSS N/A
- BCLI N/A
- Industry
- KOSS Consumer Electronics/Appliances
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KOSS Consumer Staples
- BCLI Health Care
- Exchange
- KOSS Nasdaq
- BCLI Nasdaq
- Market Cap
- KOSS 63.0M
- BCLI 25.0M
- IPO Year
- KOSS N/A
- BCLI N/A
- Fundamental
- Price
- KOSS $7.60
- BCLI $2.12
- Analyst Decision
- KOSS
- BCLI Strong Buy
- Analyst Count
- KOSS 0
- BCLI 1
- Target Price
- KOSS N/A
- BCLI $30.00
- AVG Volume (30 Days)
- KOSS 234.4K
- BCLI 86.5K
- Earning Date
- KOSS 11-01-2024
- BCLI 11-12-2024
- Dividend Yield
- KOSS N/A
- BCLI N/A
- EPS Growth
- KOSS N/A
- BCLI N/A
- EPS
- KOSS N/A
- BCLI N/A
- Revenue
- KOSS $12,265,069.00
- BCLI N/A
- Revenue This Year
- KOSS N/A
- BCLI N/A
- Revenue Next Year
- KOSS N/A
- BCLI N/A
- P/E Ratio
- KOSS N/A
- BCLI N/A
- Revenue Growth
- KOSS N/A
- BCLI N/A
- 52 Week Low
- KOSS $2.27
- BCLI $1.95
- 52 Week High
- KOSS $18.73
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- KOSS 55.73
- BCLI 31.68
- Support Level
- KOSS $6.88
- BCLI $1.97
- Resistance Level
- KOSS $8.50
- BCLI $2.68
- Average True Range (ATR)
- KOSS 0.38
- BCLI 0.29
- MACD
- KOSS 0.11
- BCLI 0.05
- Stochastic Oscillator
- KOSS 57.65
- BCLI 21.62
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.